Tracking every rollback, reversal, and overreach — and the path back to the America we know.
HHS Secretary Robert F. Kennedy Jr. directed the CDC's vaccine advisory panel to restrict access to vaccines and alter public health messaging, according to internal emails released by Senator Bernie Sanders. The action undermines independent scientific authority at the CDC and politicizes vaccine policy. The directive affects millions of Americans' access to immunizations and public health guidance.
The Trump administration issued warning letters to over 500 hospitals for failing to comply with federal price transparency requirements mandating disclosure of medical service costs. The enforcement action targets hospitals for non-compliance with existing transparency regulations aimed at reducing healthcare costs. The warnings threaten financial penalties against hospitals that do not publish accurate pricing information for procedures and services.
Senior Trump administration officials announced that Americans exposed to Ebola in Africa will be quarantined in Kenya and, if they test positive, moved to treatment facilities in Europe rather than being allowed to return to the United States. Public health experts have criticized the policy, noting that specialized treatment facilities already exist within the country. The decision contradicts standard epidemiological practice and reflects the administration's broader pattern of restricting federal health resources and capacity.
The Trump administration's cuts to U.S. and global health programs have compromised the federal government's ability to respond to hantavirus and other disease threats. Career scientists at the CDC have been fired or departed, reducing the agency's capacity to manage infectious disease outbreaks. Public health experts warn these cuts leave America unprepared for larger health crises.
The Trump administration implemented a ban on abortion care and counseling services at the Department of Veterans Affairs (VA), affecting veteran patients with reproductive health needs. A veterans advocacy group sued on behalf of affected members, including pregnant veterans with chronic medical conditions. The ban restricts access to healthcare services previously available to eligible veterans.
HHS Secretary Robert F. Kennedy Jr. extended legal protections through July 18 for manufacturers and distributors of the experimental antiviral drug favipiravir as a potential treatment for Andes hantavirus. Kennedy invoked a Public Readiness and Emergency Preparedness (PREP) Act declaration to shield drugmakers from liability. The action drew criticism from 'Make America Healthy Again' activists concerned about vaccine and pharmaceutical company immunity.
Health Secretary Robert F. Kennedy Jr. terminated the two vice chairs of the U.S. Preventive Services Task Force (USPSTF) on May 11, 2026, removing influential leaders from the panel that determines which preventive medical services insurers must cover without cost. The firings remove independent oversight from decisions affecting millions of Americans' access to free preventive care including screenings and vaccinations. The action reflects the administration's pattern of dismantling independent health agencies and scientific advisory bodies.
The Trump administration announced it would withhold $1.3 billion in Medicaid payments to California, citing insufficient state efforts to combat fraud in the public health insurance program. Vice President JD Vance justified the action as necessary to address waste in the program. The withholding directly impacts California's ability to fund Medicaid services and affects millions of beneficiaries relying on the state's healthcare coverage.
A federal appeals court ruled to eliminate telehealth prescribing of mifepristone, a common medication used for abortion and miscarriage care. This action makes it harder for Americans to access the medication and represents a step toward broader abortion restrictions. The decision was made on legal grounds rather than new safety evidence.
The FDA authorized fruit-flavored vapes for adult consumers, reversing years of aggressive regulatory efforts to restrict flavored vaping products. The decision followed pressure from President Trump on FDA leadership. This move eliminates restrictions on flavored e-cigarettes that had been in place to discourage youth vaping.